https://twitter.com/CarelonResearch/status/1722297937030762877In collaboration with @boehringerus, we conducted the first large-scale U.S. validation of a new AI-driven tool to predict risk of chronic kidney disease progression. Learn more: https://t.co/WtScZRunWG #KidneyWk #CKD #news #PressRelease https://bit.ly/4617Uy1
— Carelon Research (@CarelonResearch) Nov 8, 2023
No comments:
Post a Comment